nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Azathioprine—multiple sclerosis	0.603	1	CiPCiCtD
Fluorouracil—ALB—multiple sclerosis	0.0714	1	CbGaD
Fluorouracil—MTHFR—Methotrexate—multiple sclerosis	0.0359	0.177	CbGbCtD
Fluorouracil—TYMS—Methotrexate—multiple sclerosis	0.0306	0.151	CbGbCtD
Fluorouracil—ABCG2—Cladribine—multiple sclerosis	0.0214	0.106	CbGbCtD
Fluorouracil—ABCC3—Methotrexate—multiple sclerosis	0.0159	0.0781	CbGbCtD
Fluorouracil—ABCG2—Mitoxantrone—multiple sclerosis	0.0156	0.0771	CbGbCtD
Fluorouracil—CYP2A6—Prednisolone—multiple sclerosis	0.0149	0.0732	CbGbCtD
Fluorouracil—SLC22A7—Methotrexate—multiple sclerosis	0.0124	0.0611	CbGbCtD
Fluorouracil—ABCC4—Methotrexate—multiple sclerosis	0.0121	0.0597	CbGbCtD
Fluorouracil—ALB—Prednisone—multiple sclerosis	0.00896	0.0441	CbGbCtD
Fluorouracil—CYP2A6—Dexamethasone—multiple sclerosis	0.00876	0.0432	CbGbCtD
Fluorouracil—ABCG2—Dexamethasone—multiple sclerosis	0.00811	0.0399	CbGbCtD
Fluorouracil—ABCG2—Methotrexate—multiple sclerosis	0.00652	0.0321	CbGbCtD
Fluorouracil—ALB—Methotrexate—multiple sclerosis	0.00449	0.0221	CbGbCtD
Fluorouracil—CYP2C8—Dexamethasone—multiple sclerosis	0.00432	0.0213	CbGbCtD
Fluorouracil—CYP2C9—Dexamethasone—multiple sclerosis	0.00301	0.0148	CbGbCtD
Fluorouracil—UPP2—nervous system—multiple sclerosis	0.00119	0.0488	CbGeAlD
Fluorouracil—UPP2—central nervous system—multiple sclerosis	0.00114	0.047	CbGeAlD
Fluorouracil—UPP2—brain—multiple sclerosis	0.000907	0.0373	CbGeAlD
Fluorouracil—UMPS—medulla oblongata—multiple sclerosis	0.000896	0.0368	CbGeAlD
Fluorouracil—UPP1—medulla oblongata—multiple sclerosis	0.000822	0.0338	CbGeAlD
Fluorouracil—UMPS—midbrain—multiple sclerosis	0.000819	0.0337	CbGeAlD
Fluorouracil—PPAT—retina—multiple sclerosis	0.000799	0.0328	CbGeAlD
Fluorouracil—UPP1—midbrain—multiple sclerosis	0.000751	0.0309	CbGeAlD
Fluorouracil—UPP1—spinal cord—multiple sclerosis	0.000733	0.0301	CbGeAlD
Fluorouracil—UMPS—nervous system—multiple sclerosis	0.000673	0.0277	CbGeAlD
Fluorouracil—UMPS—central nervous system—multiple sclerosis	0.000648	0.0266	CbGeAlD
Fluorouracil—UMPS—cerebellum—multiple sclerosis	0.000634	0.026	CbGeAlD
Fluorouracil—UPP1—cerebellum—multiple sclerosis	0.000581	0.0239	CbGeAlD
Fluorouracil—PPAT—medulla oblongata—multiple sclerosis	0.000578	0.0237	CbGeAlD
Fluorouracil—PPAT—midbrain—multiple sclerosis	0.000528	0.0217	CbGeAlD
Fluorouracil—PPAT—spinal cord—multiple sclerosis	0.000515	0.0212	CbGeAlD
Fluorouracil—UMPS—brain—multiple sclerosis	0.000515	0.0212	CbGeAlD
Fluorouracil—UPP1—brain—multiple sclerosis	0.000472	0.0194	CbGeAlD
Fluorouracil—ABCC5—retina—multiple sclerosis	0.000448	0.0184	CbGeAlD
Fluorouracil—PPAT—nervous system—multiple sclerosis	0.000434	0.0178	CbGeAlD
Fluorouracil—PPAT—central nervous system—multiple sclerosis	0.000418	0.0172	CbGeAlD
Fluorouracil—PPAT—cerebellum—multiple sclerosis	0.000408	0.0168	CbGeAlD
Fluorouracil—TYMP—medulla oblongata—multiple sclerosis	0.000387	0.0159	CbGeAlD
Fluorouracil—DPYD—brain—multiple sclerosis	0.000383	0.0157	CbGeAlD
Fluorouracil—TYMP—midbrain—multiple sclerosis	0.000353	0.0145	CbGeAlD
Fluorouracil—TYMP—spinal cord—multiple sclerosis	0.000345	0.0142	CbGeAlD
Fluorouracil—PPAT—brain—multiple sclerosis	0.000332	0.0136	CbGeAlD
Fluorouracil—ABCC5—medulla oblongata—multiple sclerosis	0.000324	0.0133	CbGeAlD
Fluorouracil—TYMS—midbrain—multiple sclerosis	0.000303	0.0125	CbGeAlD
Fluorouracil—ABCC5—midbrain—multiple sclerosis	0.000296	0.0122	CbGeAlD
Fluorouracil—TYMP—nervous system—multiple sclerosis	0.00029	0.0119	CbGeAlD
Fluorouracil—TYMP—central nervous system—multiple sclerosis	0.00028	0.0115	CbGeAlD
Fluorouracil—TYMP—cerebellum—multiple sclerosis	0.000273	0.0112	CbGeAlD
Fluorouracil—MTHFR—nervous system—multiple sclerosis	0.000273	0.0112	CbGeAlD
Fluorouracil—MTHFR—central nervous system—multiple sclerosis	0.000263	0.0108	CbGeAlD
Fluorouracil—MTHFR—cerebellum—multiple sclerosis	0.000257	0.0106	CbGeAlD
Fluorouracil—TYMS—nervous system—multiple sclerosis	0.000249	0.0102	CbGeAlD
Fluorouracil—TYMS—central nervous system—multiple sclerosis	0.00024	0.00986	CbGeAlD
Fluorouracil—TYMS—cerebellum—multiple sclerosis	0.000235	0.00964	CbGeAlD
Fluorouracil—ABCC5—cerebellum—multiple sclerosis	0.000229	0.00941	CbGeAlD
Fluorouracil—SLC29A1—nervous system—multiple sclerosis	0.000224	0.00918	CbGeAlD
Fluorouracil—TYMP—brain—multiple sclerosis	0.000222	0.00912	CbGeAlD
Fluorouracil—SLC22A7—brain—multiple sclerosis	0.000221	0.0091	CbGeAlD
Fluorouracil—SLC29A1—central nervous system—multiple sclerosis	0.000215	0.00884	CbGeAlD
Fluorouracil—SLC29A1—cerebellum—multiple sclerosis	0.00021	0.00864	CbGeAlD
Fluorouracil—MTHFR—brain—multiple sclerosis	0.000209	0.00858	CbGeAlD
Fluorouracil—CYP2A6—cerebellum—multiple sclerosis	0.000205	0.00844	CbGeAlD
Fluorouracil—ABCC3—nervous system—multiple sclerosis	0.000204	0.0084	CbGeAlD
Fluorouracil—ABCC3—central nervous system—multiple sclerosis	0.000197	0.00809	CbGeAlD
Fluorouracil—TYMS—brain—multiple sclerosis	0.000191	0.00783	CbGeAlD
Fluorouracil—ABCC5—brain—multiple sclerosis	0.000186	0.00765	CbGeAlD
Fluorouracil—SLC29A1—brain—multiple sclerosis	0.000171	0.00702	CbGeAlD
Fluorouracil—ABCC4—nervous system—multiple sclerosis	0.000169	0.00693	CbGeAlD
Fluorouracil—CYP2A6—brain—multiple sclerosis	0.000167	0.00685	CbGeAlD
Fluorouracil—ABCC4—central nervous system—multiple sclerosis	0.000162	0.00668	CbGeAlD
Fluorouracil—ABCG2—medulla oblongata—multiple sclerosis	0.000159	0.00651	CbGeAlD
Fluorouracil—ABCC3—brain—multiple sclerosis	0.000156	0.00642	CbGeAlD
Fluorouracil—ABCG2—midbrain—multiple sclerosis	0.000145	0.00595	CbGeAlD
Fluorouracil—ABCG2—spinal cord—multiple sclerosis	0.000141	0.00581	CbGeAlD
Fluorouracil—ALB—brain—multiple sclerosis	0.000133	0.00548	CbGeAlD
Fluorouracil—ABCC4—brain—multiple sclerosis	0.000129	0.0053	CbGeAlD
Fluorouracil—ABCG2—cerebellum—multiple sclerosis	0.000112	0.00461	CbGeAlD
Fluorouracil—CYP2C8—brain—multiple sclerosis	9.36e-05	0.00385	CbGeAlD
Fluorouracil—ABCG2—brain—multiple sclerosis	9.1e-05	0.00374	CbGeAlD
Fluorouracil—TYMS—Azacitidine—Cladribine—multiple sclerosis	7.69e-05	0.0491	CbGdCrCtD
Fluorouracil—Anorexia—Mitoxantrone—multiple sclerosis	6.9e-05	0.00109	CcSEcCtD
Fluorouracil—Ataxia—Methotrexate—multiple sclerosis	6.9e-05	0.00109	CcSEcCtD
Fluorouracil—Headache—Cladribine—multiple sclerosis	6.9e-05	0.00109	CcSEcCtD
Fluorouracil—Arrhythmia—Triamcinolone—multiple sclerosis	6.87e-05	0.00109	CcSEcCtD
Fluorouracil—Vision blurred—Prednisolone—multiple sclerosis	6.86e-05	0.00109	CcSEcCtD
Fluorouracil—Arrhythmia—Methylprednisolone—multiple sclerosis	6.85e-05	0.00109	CcSEcCtD
Fluorouracil—Hypotension—Mitoxantrone—multiple sclerosis	6.76e-05	0.00107	CcSEcCtD
Fluorouracil—Erythema—Triamcinolone—multiple sclerosis	6.69e-05	0.00106	CcSEcCtD
Fluorouracil—Erythema—Methylprednisolone—multiple sclerosis	6.68e-05	0.00106	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Prednisone—multiple sclerosis	6.67e-05	0.00106	CcSEcCtD
Fluorouracil—Myocardial infarction—Prednisone—multiple sclerosis	6.63e-05	0.00105	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Prednisone—multiple sclerosis	6.63e-05	0.00105	CcSEcCtD
Fluorouracil—Hypersensitivity—Azathioprine—multiple sclerosis	6.6e-05	0.00105	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	6.6e-05	0.00104	CcSEcCtD
Fluorouracil—Nausea—Cladribine—multiple sclerosis	6.54e-05	0.00104	CcSEcCtD
Fluorouracil—Paraesthesia—Mitoxantrone—multiple sclerosis	6.5e-05	0.00103	CcSEcCtD
Fluorouracil—Dyspnoea—Mitoxantrone—multiple sclerosis	6.45e-05	0.00102	CcSEcCtD
Fluorouracil—Somnolence—Mitoxantrone—multiple sclerosis	6.44e-05	0.00102	CcSEcCtD
Fluorouracil—Dyspepsia—Mitoxantrone—multiple sclerosis	6.37e-05	0.00101	CcSEcCtD
Fluorouracil—Convulsion—Prednisolone—multiple sclerosis	6.31e-05	0.000999	CcSEcCtD
Fluorouracil—Decreased appetite—Mitoxantrone—multiple sclerosis	6.29e-05	0.000997	CcSEcCtD
Fluorouracil—Eosinophilia—Methotrexate—multiple sclerosis	6.28e-05	0.000995	CcSEcCtD
Fluorouracil—Arrhythmia—Betamethasone—multiple sclerosis	6.23e-05	0.000987	CcSEcCtD
Fluorouracil—Arrhythmia—Dexamethasone—multiple sclerosis	6.23e-05	0.000987	CcSEcCtD
Fluorouracil—Pain—Mitoxantrone—multiple sclerosis	6.19e-05	0.000981	CcSEcCtD
Fluorouracil—Alopecia—Dexamethasone—multiple sclerosis	6.16e-05	0.000977	CcSEcCtD
Fluorouracil—Alopecia—Betamethasone—multiple sclerosis	6.16e-05	0.000977	CcSEcCtD
Fluorouracil—Diarrhoea—Azathioprine—multiple sclerosis	6.13e-05	0.000971	CcSEcCtD
Fluorouracil—Discomfort—Prednisolone—multiple sclerosis	6.12e-05	0.00097	CcSEcCtD
Fluorouracil—Haemoglobin—Prednisone—multiple sclerosis	6.11e-05	0.000967	CcSEcCtD
Fluorouracil—Haemorrhage—Prednisone—multiple sclerosis	6.07e-05	0.000962	CcSEcCtD
Fluorouracil—Erythema—Betamethasone—multiple sclerosis	6.07e-05	0.000962	CcSEcCtD
Fluorouracil—Erythema—Dexamethasone—multiple sclerosis	6.07e-05	0.000962	CcSEcCtD
Fluorouracil—Pancytopenia—Methotrexate—multiple sclerosis	6.02e-05	0.000954	CcSEcCtD
Fluorouracil—Feeling abnormal—Mitoxantrone—multiple sclerosis	5.97e-05	0.000945	CcSEcCtD
Fluorouracil—Anaphylactic shock—Prednisolone—multiple sclerosis	5.94e-05	0.000941	CcSEcCtD
Fluorouracil—Oedema—Prednisolone—multiple sclerosis	5.94e-05	0.000941	CcSEcCtD
Fluorouracil—Dizziness—Azathioprine—multiple sclerosis	5.92e-05	0.000938	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Methotrexate—multiple sclerosis	5.89e-05	0.000934	CcSEcCtD
Fluorouracil—Convulsion—Triamcinolone—multiple sclerosis	5.8e-05	0.000919	CcSEcCtD
Fluorouracil—Tachycardia—Prednisolone—multiple sclerosis	5.8e-05	0.000918	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Methotrexate—multiple sclerosis	5.79e-05	0.000917	CcSEcCtD
Fluorouracil—Convulsion—Methylprednisolone—multiple sclerosis	5.79e-05	0.000917	CcSEcCtD
Fluorouracil—Urticaria—Mitoxantrone—multiple sclerosis	5.75e-05	0.000911	CcSEcCtD
Fluorouracil—Body temperature increased—Mitoxantrone—multiple sclerosis	5.72e-05	0.000907	CcSEcCtD
Fluorouracil—Myalgia—Triamcinolone—multiple sclerosis	5.7e-05	0.000903	CcSEcCtD
Fluorouracil—Vomiting—Azathioprine—multiple sclerosis	5.69e-05	0.000902	CcSEcCtD
Fluorouracil—Pneumonia—Methotrexate—multiple sclerosis	5.69e-05	0.000901	CcSEcCtD
Fluorouracil—Myalgia—Methylprednisolone—multiple sclerosis	5.68e-05	0.000901	CcSEcCtD
Fluorouracil—Infestation NOS—Methotrexate—multiple sclerosis	5.66e-05	0.000896	CcSEcCtD
Fluorouracil—Infestation—Methotrexate—multiple sclerosis	5.66e-05	0.000896	CcSEcCtD
Fluorouracil—Rash—Azathioprine—multiple sclerosis	5.65e-05	0.000895	CcSEcCtD
Fluorouracil—Dermatitis—Azathioprine—multiple sclerosis	5.64e-05	0.000894	CcSEcCtD
Fluorouracil—Discomfort—Triamcinolone—multiple sclerosis	5.63e-05	0.000892	CcSEcCtD
Fluorouracil—Discomfort—Methylprednisolone—multiple sclerosis	5.62e-05	0.00089	CcSEcCtD
Fluorouracil—Headache—Azathioprine—multiple sclerosis	5.61e-05	0.000889	CcSEcCtD
Fluorouracil—Stomatitis—Methotrexate—multiple sclerosis	5.51e-05	0.000873	CcSEcCtD
Fluorouracil—Conjunctivitis—Methotrexate—multiple sclerosis	5.5e-05	0.000871	CcSEcCtD
Fluorouracil—Confusional state—Methylprednisolone—multiple sclerosis	5.49e-05	0.000871	CcSEcCtD
Fluorouracil—Oedema—Triamcinolone—multiple sclerosis	5.46e-05	0.000865	CcSEcCtD
Fluorouracil—Anaphylactic shock—Triamcinolone—multiple sclerosis	5.46e-05	0.000865	CcSEcCtD
Fluorouracil—Anaphylactic shock—Methylprednisolone—multiple sclerosis	5.45e-05	0.000863	CcSEcCtD
Fluorouracil—Arrhythmia—Prednisone—multiple sclerosis	5.43e-05	0.00086	CcSEcCtD
Fluorouracil—Infection—Triamcinolone—multiple sclerosis	5.43e-05	0.00086	CcSEcCtD
Fluorouracil—Infection—Methylprednisolone—multiple sclerosis	5.41e-05	0.000858	CcSEcCtD
Fluorouracil—Insomnia—Prednisolone—multiple sclerosis	5.37e-05	0.000851	CcSEcCtD
Fluorouracil—Alopecia—Prednisone—multiple sclerosis	5.37e-05	0.00085	CcSEcCtD
Fluorouracil—Nervous system disorder—Methylprednisolone—multiple sclerosis	5.34e-05	0.000847	CcSEcCtD
Fluorouracil—Epistaxis—Methotrexate—multiple sclerosis	5.33e-05	0.000845	CcSEcCtD
Fluorouracil—Hypersensitivity—Mitoxantrone—multiple sclerosis	5.33e-05	0.000845	CcSEcCtD
Fluorouracil—Paraesthesia—Prednisolone—multiple sclerosis	5.33e-05	0.000845	CcSEcCtD
Fluorouracil—Tachycardia—Triamcinolone—multiple sclerosis	5.33e-05	0.000845	CcSEcCtD
Fluorouracil—Nausea—Azathioprine—multiple sclerosis	5.32e-05	0.000843	CcSEcCtD
Fluorouracil—Tachycardia—Methylprednisolone—multiple sclerosis	5.32e-05	0.000843	CcSEcCtD
Fluorouracil—Erythema—Prednisone—multiple sclerosis	5.29e-05	0.000838	CcSEcCtD
Fluorouracil—Agranulocytosis—Methotrexate—multiple sclerosis	5.28e-05	0.000836	CcSEcCtD
Fluorouracil—Convulsion—Betamethasone—multiple sclerosis	5.26e-05	0.000834	CcSEcCtD
Fluorouracil—Convulsion—Dexamethasone—multiple sclerosis	5.26e-05	0.000834	CcSEcCtD
Fluorouracil—Myalgia—Betamethasone—multiple sclerosis	5.17e-05	0.000819	CcSEcCtD
Fluorouracil—Myalgia—Dexamethasone—multiple sclerosis	5.17e-05	0.000819	CcSEcCtD
Fluorouracil—Discomfort—Betamethasone—multiple sclerosis	5.11e-05	0.000809	CcSEcCtD
Fluorouracil—Discomfort—Dexamethasone—multiple sclerosis	5.11e-05	0.000809	CcSEcCtD
Fluorouracil—Haemoglobin—Methotrexate—multiple sclerosis	5.1e-05	0.000808	CcSEcCtD
Fluorouracil—Hypotension—Methylprednisolone—multiple sclerosis	5.09e-05	0.000807	CcSEcCtD
Fluorouracil—Pain—Prednisolone—multiple sclerosis	5.08e-05	0.000805	CcSEcCtD
Fluorouracil—Haemorrhage—Methotrexate—multiple sclerosis	5.08e-05	0.000804	CcSEcCtD
Fluorouracil—Pharyngitis—Methotrexate—multiple sclerosis	5.04e-05	0.000798	CcSEcCtD
Fluorouracil—Vision blurred—Prednisone—multiple sclerosis	4.98e-05	0.00079	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	4.98e-05	0.000788	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	4.96e-05	0.000787	CcSEcCtD
Fluorouracil—Oedema—Dexamethasone—multiple sclerosis	4.96e-05	0.000785	CcSEcCtD
Fluorouracil—Anaphylactic shock—Dexamethasone—multiple sclerosis	4.96e-05	0.000785	CcSEcCtD
Fluorouracil—Anaphylactic shock—Betamethasone—multiple sclerosis	4.96e-05	0.000785	CcSEcCtD
Fluorouracil—Oedema—Betamethasone—multiple sclerosis	4.96e-05	0.000785	CcSEcCtD
Fluorouracil—Diarrhoea—Mitoxantrone—multiple sclerosis	4.95e-05	0.000785	CcSEcCtD
Fluorouracil—Insomnia—Triamcinolone—multiple sclerosis	4.94e-05	0.000783	CcSEcCtD
Fluorouracil—TYMS—Clobetasol propionate—Methylprednisolone—multiple sclerosis	4.93e-05	0.0315	CbGdCrCtD
Fluorouracil—Insomnia—Methylprednisolone—multiple sclerosis	4.93e-05	0.000781	CcSEcCtD
Fluorouracil—Infection—Dexamethasone—multiple sclerosis	4.92e-05	0.00078	CcSEcCtD
Fluorouracil—Infection—Betamethasone—multiple sclerosis	4.92e-05	0.00078	CcSEcCtD
Fluorouracil—Paraesthesia—Triamcinolone—multiple sclerosis	4.9e-05	0.000777	CcSEcCtD
Fluorouracil—Feeling abnormal—Prednisolone—multiple sclerosis	4.89e-05	0.000775	CcSEcCtD
Fluorouracil—Paraesthesia—Methylprednisolone—multiple sclerosis	4.89e-05	0.000775	CcSEcCtD
Fluorouracil—Anaemia—Prednisone—multiple sclerosis	4.89e-05	0.000774	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Methylprednisolone—multiple sclerosis	4.87e-05	0.0311	CbGdCrCtD
Fluorouracil—Dyspnoea—Triamcinolone—multiple sclerosis	4.87e-05	0.000771	CcSEcCtD
Fluorouracil—Nervous system disorder—Betamethasone—multiple sclerosis	4.86e-05	0.00077	CcSEcCtD
Fluorouracil—Nervous system disorder—Dexamethasone—multiple sclerosis	4.86e-05	0.00077	CcSEcCtD
Fluorouracil—TYMS—Clobetasol propionate—Betamethasone—multiple sclerosis	4.86e-05	0.031	CbGdCrCtD
Fluorouracil—TYMS—Clobetasol propionate—Dexamethasone—multiple sclerosis	4.86e-05	0.031	CbGdCrCtD
Fluorouracil—Thrombocytopenia—Betamethasone—multiple sclerosis	4.85e-05	0.000769	CcSEcCtD
Fluorouracil—Thrombocytopenia—Dexamethasone—multiple sclerosis	4.85e-05	0.000769	CcSEcCtD
Fluorouracil—Tachycardia—Betamethasone—multiple sclerosis	4.84e-05	0.000766	CcSEcCtD
Fluorouracil—Tachycardia—Dexamethasone—multiple sclerosis	4.84e-05	0.000766	CcSEcCtD
Fluorouracil—TYMS—Triamcinolone—Methylprednisolone—multiple sclerosis	4.82e-05	0.0308	CbGdCrCtD
Fluorouracil—Dyspepsia—Triamcinolone—multiple sclerosis	4.81e-05	0.000762	CcSEcCtD
Fluorouracil—Dyspepsia—Methylprednisolone—multiple sclerosis	4.8e-05	0.00076	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Betamethasone—multiple sclerosis	4.79e-05	0.0306	CbGdCrCtD
Fluorouracil—TYMS—Flunisolide—Dexamethasone—multiple sclerosis	4.79e-05	0.0306	CbGdCrCtD
Fluorouracil—TYMS—Clobetasol propionate—Triamcinolone—multiple sclerosis	4.75e-05	0.0303	CbGdCrCtD
Fluorouracil—TYMS—Triamcinolone—Dexamethasone—multiple sclerosis	4.74e-05	0.0303	CbGdCrCtD
Fluorouracil—TYMS—Triamcinolone—Betamethasone—multiple sclerosis	4.74e-05	0.0303	CbGdCrCtD
Fluorouracil—Anorexia—Betamethasone—multiple sclerosis	4.72e-05	0.000748	CcSEcCtD
Fluorouracil—Anorexia—Dexamethasone—multiple sclerosis	4.72e-05	0.000748	CcSEcCtD
Fluorouracil—Urticaria—Prednisolone—multiple sclerosis	4.72e-05	0.000747	CcSEcCtD
Fluorouracil—TYMS—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	4.7e-05	0.03	CbGdCrCtD
Fluorouracil—TYMS—Flunisolide—Triamcinolone—multiple sclerosis	4.68e-05	0.0299	CbGdCrCtD
Fluorouracil—Pain—Triamcinolone—multiple sclerosis	4.67e-05	0.00074	CcSEcCtD
Fluorouracil—Hypotension—Betamethasone—multiple sclerosis	4.63e-05	0.000734	CcSEcCtD
Fluorouracil—Hypotension—Dexamethasone—multiple sclerosis	4.63e-05	0.000734	CcSEcCtD
Fluorouracil—TYMS—Fluticasone Propionate—Dexamethasone—multiple sclerosis	4.63e-05	0.0295	CbGdCrCtD
Fluorouracil—TYMS—Fluticasone Propionate—Betamethasone—multiple sclerosis	4.63e-05	0.0295	CbGdCrCtD
Fluorouracil—Vomiting—Mitoxantrone—multiple sclerosis	4.6e-05	0.000729	CcSEcCtD
Fluorouracil—Convulsion—Prednisone—multiple sclerosis	4.58e-05	0.000726	CcSEcCtD
Fluorouracil—Rash—Mitoxantrone—multiple sclerosis	4.56e-05	0.000723	CcSEcCtD
Fluorouracil—Dermatitis—Mitoxantrone—multiple sclerosis	4.56e-05	0.000722	CcSEcCtD
Fluorouracil—Headache—Mitoxantrone—multiple sclerosis	4.54e-05	0.000718	CcSEcCtD
Fluorouracil—TYMS—Fluticasone Propionate—Triamcinolone—multiple sclerosis	4.52e-05	0.0289	CbGdCrCtD
Fluorouracil—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	4.52e-05	0.000715	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	4.52e-05	0.000715	CcSEcCtD
Fluorouracil—TYMS—Clobetasol propionate—Prednisone—multiple sclerosis	4.5e-05	0.0288	CbGdCrCtD
Fluorouracil—Myalgia—Prednisone—multiple sclerosis	4.5e-05	0.000713	CcSEcCtD
Fluorouracil—Feeling abnormal—Triamcinolone—multiple sclerosis	4.5e-05	0.000713	CcSEcCtD
Fluorouracil—Feeling abnormal—Methylprednisolone—multiple sclerosis	4.49e-05	0.000711	CcSEcCtD
Fluorouracil—Alopecia—Methotrexate—multiple sclerosis	4.49e-05	0.000711	CcSEcCtD
Fluorouracil—Insomnia—Dexamethasone—multiple sclerosis	4.48e-05	0.00071	CcSEcCtD
Fluorouracil—Insomnia—Betamethasone—multiple sclerosis	4.48e-05	0.00071	CcSEcCtD
Fluorouracil—Paraesthesia—Dexamethasone—multiple sclerosis	4.45e-05	0.000705	CcSEcCtD
Fluorouracil—Paraesthesia—Betamethasone—multiple sclerosis	4.45e-05	0.000705	CcSEcCtD
Fluorouracil—Discomfort—Prednisone—multiple sclerosis	4.45e-05	0.000705	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Prednisone—multiple sclerosis	4.44e-05	0.0284	CbGdCrCtD
Fluorouracil—TYMS—Diflorasone—Methylprednisolone—multiple sclerosis	4.44e-05	0.0284	CbGdCrCtD
Fluorouracil—Erythema—Methotrexate—multiple sclerosis	4.42e-05	0.0007	CcSEcCtD
Fluorouracil—TYMS—Triamcinolone—Prednisone—multiple sclerosis	4.4e-05	0.0281	CbGdCrCtD
Fluorouracil—TYMS—Clobetasol propionate—Prednisolone—multiple sclerosis	4.4e-05	0.0281	CbGdCrCtD
Fluorouracil—Hypersensitivity—Prednisolone—multiple sclerosis	4.38e-05	0.000693	CcSEcCtD
Fluorouracil—TYMS—Diflorasone—Betamethasone—multiple sclerosis	4.37e-05	0.0279	CbGdCrCtD
Fluorouracil—TYMS—Diflorasone—Dexamethasone—multiple sclerosis	4.37e-05	0.0279	CbGdCrCtD
Fluorouracil—Dyspepsia—Dexamethasone—multiple sclerosis	4.36e-05	0.000691	CcSEcCtD
Fluorouracil—Dyspepsia—Betamethasone—multiple sclerosis	4.36e-05	0.000691	CcSEcCtD
Fluorouracil—Urticaria—Triamcinolone—multiple sclerosis	4.34e-05	0.000687	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Prednisolone—multiple sclerosis	4.34e-05	0.0277	CbGdCrCtD
Fluorouracil—Urticaria—Methylprednisolone—multiple sclerosis	4.33e-05	0.000686	CcSEcCtD
Fluorouracil—Body temperature increased—Triamcinolone—multiple sclerosis	4.32e-05	0.000684	CcSEcCtD
Fluorouracil—Oedema—Prednisone—multiple sclerosis	4.32e-05	0.000684	CcSEcCtD
Fluorouracil—Anaphylactic shock—Prednisone—multiple sclerosis	4.32e-05	0.000684	CcSEcCtD
Fluorouracil—Decreased appetite—Dexamethasone—multiple sclerosis	4.31e-05	0.000683	CcSEcCtD
Fluorouracil—Decreased appetite—Betamethasone—multiple sclerosis	4.31e-05	0.000683	CcSEcCtD
Fluorouracil—Nausea—Mitoxantrone—multiple sclerosis	4.3e-05	0.000681	CcSEcCtD
Fluorouracil—TYMS—Triamcinolone—Prednisolone—multiple sclerosis	4.29e-05	0.0274	CbGdCrCtD
Fluorouracil—Infection—Prednisone—multiple sclerosis	4.29e-05	0.000679	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Betamethasone—multiple sclerosis	4.28e-05	0.000678	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	4.28e-05	0.000678	CcSEcCtD
Fluorouracil—TYMS—Diflorasone—Triamcinolone—multiple sclerosis	4.27e-05	0.0273	CbGdCrCtD
Fluorouracil—Pain—Dexamethasone—multiple sclerosis	4.24e-05	0.000671	CcSEcCtD
Fluorouracil—Pain—Betamethasone—multiple sclerosis	4.24e-05	0.000671	CcSEcCtD
Fluorouracil—Nervous system disorder—Prednisone—multiple sclerosis	4.23e-05	0.000671	CcSEcCtD
Fluorouracil—Tachycardia—Prednisone—multiple sclerosis	4.21e-05	0.000667	CcSEcCtD
Fluorouracil—Vision blurred—Methotrexate—multiple sclerosis	4.16e-05	0.00066	CcSEcCtD
Fluorouracil—Anorexia—Prednisone—multiple sclerosis	4.11e-05	0.000652	CcSEcCtD
Fluorouracil—Anaemia—Methotrexate—multiple sclerosis	4.08e-05	0.000647	CcSEcCtD
Fluorouracil—Feeling abnormal—Dexamethasone—multiple sclerosis	4.08e-05	0.000647	CcSEcCtD
Fluorouracil—Feeling abnormal—Betamethasone—multiple sclerosis	4.08e-05	0.000647	CcSEcCtD
Fluorouracil—TYMS—Diflorasone—Prednisone—multiple sclerosis	4.05e-05	0.0259	CbGdCrCtD
Fluorouracil—Hypersensitivity—Triamcinolone—multiple sclerosis	4.02e-05	0.000638	CcSEcCtD
Fluorouracil—Hypersensitivity—Methylprednisolone—multiple sclerosis	4.02e-05	0.000636	CcSEcCtD
Fluorouracil—TYMS—Diflorasone—Prednisolone—multiple sclerosis	3.96e-05	0.0253	CbGdCrCtD
Fluorouracil—Leukopenia—Methotrexate—multiple sclerosis	3.96e-05	0.000627	CcSEcCtD
Fluorouracil—Urticaria—Dexamethasone—multiple sclerosis	3.94e-05	0.000624	CcSEcCtD
Fluorouracil—Urticaria—Betamethasone—multiple sclerosis	3.94e-05	0.000624	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Prednisone—multiple sclerosis	3.93e-05	0.000623	CcSEcCtD
Fluorouracil—Dizziness—Prednisolone—multiple sclerosis	3.93e-05	0.000622	CcSEcCtD
Fluorouracil—Body temperature increased—Dexamethasone—multiple sclerosis	3.92e-05	0.000621	CcSEcCtD
Fluorouracil—Body temperature increased—Betamethasone—multiple sclerosis	3.92e-05	0.000621	CcSEcCtD
Fluorouracil—Insomnia—Prednisone—multiple sclerosis	3.9e-05	0.000618	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Methylprednisolone—multiple sclerosis	3.9e-05	0.0249	CbGdCrCtD
Fluorouracil—Paraesthesia—Prednisone—multiple sclerosis	3.88e-05	0.000614	CcSEcCtD
Fluorouracil—Pruritus—Triamcinolone—multiple sclerosis	3.86e-05	0.000612	CcSEcCtD
Fluorouracil—Pruritus—Methylprednisolone—multiple sclerosis	3.86e-05	0.000611	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Dexamethasone—multiple sclerosis	3.83e-05	0.0245	CbGdCrCtD
Fluorouracil—TYMS—Budesonide—Betamethasone—multiple sclerosis	3.83e-05	0.0245	CbGdCrCtD
Fluorouracil—Convulsion—Methotrexate—multiple sclerosis	3.83e-05	0.000607	CcSEcCtD
Fluorouracil—Dyspepsia—Prednisone—multiple sclerosis	3.8e-05	0.000602	CcSEcCtD
Fluorouracil—Chest pain—Methotrexate—multiple sclerosis	3.76e-05	0.000596	CcSEcCtD
Fluorouracil—Myalgia—Methotrexate—multiple sclerosis	3.76e-05	0.000596	CcSEcCtD
Fluorouracil—Decreased appetite—Prednisone—multiple sclerosis	3.75e-05	0.000594	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Triamcinolone—multiple sclerosis	3.75e-05	0.0239	CbGdCrCtD
Fluorouracil—Rash—Prednisolone—multiple sclerosis	3.74e-05	0.000593	CcSEcCtD
Fluorouracil—Dermatitis—Prednisolone—multiple sclerosis	3.74e-05	0.000593	CcSEcCtD
Fluorouracil—Diarrhoea—Methylprednisolone—multiple sclerosis	3.73e-05	0.000591	CcSEcCtD
Fluorouracil—Headache—Prednisolone—multiple sclerosis	3.72e-05	0.000589	CcSEcCtD
Fluorouracil—Discomfort—Methotrexate—multiple sclerosis	3.72e-05	0.000589	CcSEcCtD
Fluorouracil—Confusional state—Methotrexate—multiple sclerosis	3.64e-05	0.000576	CcSEcCtD
Fluorouracil—Dizziness—Triamcinolone—multiple sclerosis	3.61e-05	0.000572	CcSEcCtD
Fluorouracil—Anaphylactic shock—Methotrexate—multiple sclerosis	3.61e-05	0.000571	CcSEcCtD
Fluorouracil—Dizziness—Methylprednisolone—multiple sclerosis	3.6e-05	0.000571	CcSEcCtD
Fluorouracil—Infection—Methotrexate—multiple sclerosis	3.58e-05	0.000568	CcSEcCtD
Fluorouracil—Feeling abnormal—Prednisone—multiple sclerosis	3.56e-05	0.000563	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Prednisone—multiple sclerosis	3.55e-05	0.0227	CbGdCrCtD
Fluorouracil—Nervous system disorder—Methotrexate—multiple sclerosis	3.54e-05	0.00056	CcSEcCtD
Fluorouracil—Thrombocytopenia—Methotrexate—multiple sclerosis	3.53e-05	0.000559	CcSEcCtD
Fluorouracil—Nausea—Prednisolone—multiple sclerosis	3.53e-05	0.000559	CcSEcCtD
Fluorouracil—Pruritus—Betamethasone—multiple sclerosis	3.51e-05	0.000555	CcSEcCtD
Fluorouracil—Pruritus—Dexamethasone—multiple sclerosis	3.51e-05	0.000555	CcSEcCtD
Fluorouracil—Vomiting—Triamcinolone—multiple sclerosis	3.47e-05	0.00055	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Prednisolone—multiple sclerosis	3.47e-05	0.0222	CbGdCrCtD
Fluorouracil—Vomiting—Methylprednisolone—multiple sclerosis	3.46e-05	0.000549	CcSEcCtD
Fluorouracil—Rash—Triamcinolone—multiple sclerosis	3.44e-05	0.000546	CcSEcCtD
Fluorouracil—Dermatitis—Triamcinolone—multiple sclerosis	3.44e-05	0.000545	CcSEcCtD
Fluorouracil—Anorexia—Methotrexate—multiple sclerosis	3.44e-05	0.000545	CcSEcCtD
Fluorouracil—Rash—Methylprednisolone—multiple sclerosis	3.44e-05	0.000544	CcSEcCtD
Fluorouracil—Dermatitis—Methylprednisolone—multiple sclerosis	3.43e-05	0.000544	CcSEcCtD
Fluorouracil—Urticaria—Prednisone—multiple sclerosis	3.43e-05	0.000543	CcSEcCtD
Fluorouracil—Headache—Triamcinolone—multiple sclerosis	3.42e-05	0.000542	CcSEcCtD
Fluorouracil—Headache—Methylprednisolone—multiple sclerosis	3.41e-05	0.000541	CcSEcCtD
Fluorouracil—Body temperature increased—Prednisone—multiple sclerosis	3.41e-05	0.000541	CcSEcCtD
Fluorouracil—TYMS—Danazol—Prednisone—multiple sclerosis	3.41e-05	0.0218	CbGdCrCtD
Fluorouracil—Diarrhoea—Dexamethasone—multiple sclerosis	3.39e-05	0.000537	CcSEcCtD
Fluorouracil—Diarrhoea—Betamethasone—multiple sclerosis	3.39e-05	0.000537	CcSEcCtD
Fluorouracil—Hypotension—Methotrexate—multiple sclerosis	3.37e-05	0.000534	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	3.29e-05	0.000521	CcSEcCtD
Fluorouracil—Dizziness—Betamethasone—multiple sclerosis	3.28e-05	0.000519	CcSEcCtD
Fluorouracil—Dizziness—Dexamethasone—multiple sclerosis	3.28e-05	0.000519	CcSEcCtD
Fluorouracil—Insomnia—Methotrexate—multiple sclerosis	3.26e-05	0.000517	CcSEcCtD
Fluorouracil—Nausea—Triamcinolone—multiple sclerosis	3.24e-05	0.000514	CcSEcCtD
Fluorouracil—Paraesthesia—Methotrexate—multiple sclerosis	3.24e-05	0.000513	CcSEcCtD
Fluorouracil—Nausea—Methylprednisolone—multiple sclerosis	3.24e-05	0.000513	CcSEcCtD
Fluorouracil—Dyspnoea—Methotrexate—multiple sclerosis	3.22e-05	0.000509	CcSEcCtD
Fluorouracil—Somnolence—Methotrexate—multiple sclerosis	3.21e-05	0.000508	CcSEcCtD
Fluorouracil—Hypersensitivity—Prednisone—multiple sclerosis	3.18e-05	0.000504	CcSEcCtD
Fluorouracil—Dyspepsia—Methotrexate—multiple sclerosis	3.17e-05	0.000503	CcSEcCtD
Fluorouracil—Vomiting—Dexamethasone—multiple sclerosis	3.15e-05	0.000499	CcSEcCtD
Fluorouracil—Vomiting—Betamethasone—multiple sclerosis	3.15e-05	0.000499	CcSEcCtD
Fluorouracil—Decreased appetite—Methotrexate—multiple sclerosis	3.14e-05	0.000497	CcSEcCtD
Fluorouracil—Rash—Betamethasone—multiple sclerosis	3.12e-05	0.000495	CcSEcCtD
Fluorouracil—Rash—Dexamethasone—multiple sclerosis	3.12e-05	0.000495	CcSEcCtD
Fluorouracil—Dermatitis—Betamethasone—multiple sclerosis	3.12e-05	0.000495	CcSEcCtD
Fluorouracil—Dermatitis—Dexamethasone—multiple sclerosis	3.12e-05	0.000495	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Methotrexate—multiple sclerosis	3.11e-05	0.000493	CcSEcCtD
Fluorouracil—Headache—Betamethasone—multiple sclerosis	3.1e-05	0.000492	CcSEcCtD
Fluorouracil—Headache—Dexamethasone—multiple sclerosis	3.1e-05	0.000492	CcSEcCtD
Fluorouracil—Pain—Methotrexate—multiple sclerosis	3.08e-05	0.000489	CcSEcCtD
Fluorouracil—Pruritus—Prednisone—multiple sclerosis	3.05e-05	0.000484	CcSEcCtD
Fluorouracil—Feeling abnormal—Methotrexate—multiple sclerosis	2.97e-05	0.000471	CcSEcCtD
Fluorouracil—Diarrhoea—Prednisone—multiple sclerosis	2.95e-05	0.000468	CcSEcCtD
Fluorouracil—Nausea—Betamethasone—multiple sclerosis	2.94e-05	0.000466	CcSEcCtD
Fluorouracil—Nausea—Dexamethasone—multiple sclerosis	2.94e-05	0.000466	CcSEcCtD
Fluorouracil—Urticaria—Methotrexate—multiple sclerosis	2.87e-05	0.000454	CcSEcCtD
Fluorouracil—Dizziness—Prednisone—multiple sclerosis	2.85e-05	0.000452	CcSEcCtD
Fluorouracil—Body temperature increased—Methotrexate—multiple sclerosis	2.85e-05	0.000452	CcSEcCtD
Fluorouracil—Vomiting—Prednisone—multiple sclerosis	2.74e-05	0.000435	CcSEcCtD
Fluorouracil—Rash—Prednisone—multiple sclerosis	2.72e-05	0.000431	CcSEcCtD
Fluorouracil—Dermatitis—Prednisone—multiple sclerosis	2.72e-05	0.000431	CcSEcCtD
Fluorouracil—Headache—Prednisone—multiple sclerosis	2.7e-05	0.000428	CcSEcCtD
Fluorouracil—Hypersensitivity—Methotrexate—multiple sclerosis	2.66e-05	0.000421	CcSEcCtD
Fluorouracil—Nausea—Prednisone—multiple sclerosis	2.56e-05	0.000406	CcSEcCtD
Fluorouracil—ABCC4—Platelet degranulation—TGFB1—multiple sclerosis	2.56e-05	0.000759	CbGpPWpGaD
Fluorouracil—Pruritus—Methotrexate—multiple sclerosis	2.55e-05	0.000404	CcSEcCtD
Fluorouracil—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.55e-05	0.000754	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.52e-05	0.000746	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.49e-05	0.000736	CbGpPWpGaD
Fluorouracil—Diarrhoea—Methotrexate—multiple sclerosis	2.47e-05	0.000391	CcSEcCtD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2.44e-05	0.000723	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—APOE—multiple sclerosis	2.44e-05	0.000722	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—APOE—multiple sclerosis	2.44e-05	0.000722	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GPC5—multiple sclerosis	2.42e-05	0.000716	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	2.4e-05	0.00071	CbGpPWpGaD
Fluorouracil—Dizziness—Methotrexate—multiple sclerosis	2.39e-05	0.000378	CcSEcCtD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.37e-05	0.000701	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CYP24A1—multiple sclerosis	2.35e-05	0.000697	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CYP27B1—multiple sclerosis	2.35e-05	0.000697	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.34e-05	0.000692	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—RRM1—multiple sclerosis	2.3e-05	0.000681	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—CCL2—multiple sclerosis	2.3e-05	0.00068	CbGpPWpGaD
Fluorouracil—Vomiting—Methotrexate—multiple sclerosis	2.29e-05	0.000363	CcSEcCtD
Fluorouracil—ABCC5—NRF2 pathway—TGFB1—multiple sclerosis	2.29e-05	0.000677	CbGpPWpGaD
Fluorouracil—Rash—Methotrexate—multiple sclerosis	2.27e-05	0.00036	CcSEcCtD
Fluorouracil—Dermatitis—Methotrexate—multiple sclerosis	2.27e-05	0.00036	CcSEcCtD
Fluorouracil—Headache—Methotrexate—multiple sclerosis	2.26e-05	0.000358	CcSEcCtD
Fluorouracil—UMPS—Metabolism—POMC—multiple sclerosis	2.25e-05	0.000667	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.23e-05	0.00066	CbGpPWpGaD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—MYC—multiple sclerosis	2.17e-05	0.000643	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—RPL5—multiple sclerosis	2.16e-05	0.000638	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GPC5—multiple sclerosis	2.15e-05	0.000637	CbGpPWpGaD
Fluorouracil—Nausea—Methotrexate—multiple sclerosis	2.14e-05	0.000339	CcSEcCtD
Fluorouracil—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	2.14e-05	0.000633	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—POMC—multiple sclerosis	2.1e-05	0.00062	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—POMC—multiple sclerosis	2.1e-05	0.00062	CbGpPWpGaD
Fluorouracil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.07e-05	0.000614	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—SLC11A1—multiple sclerosis	2.06e-05	0.000611	CbGpPWpGaD
Fluorouracil—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.06e-05	0.000611	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—ALB—multiple sclerosis	2.06e-05	0.000608	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	2.04e-05	0.000603	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—BCHE—multiple sclerosis	2e-05	0.000593	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—RRM1—multiple sclerosis	2e-05	0.000593	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	1.98e-05	0.000587	CbGpPWpGaD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.96e-05	0.00058	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—IFNG—multiple sclerosis	1.95e-05	0.000578	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CYP27B1—multiple sclerosis	1.95e-05	0.000577	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CYP24A1—multiple sclerosis	1.95e-05	0.000577	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—ALB—multiple sclerosis	1.91e-05	0.000566	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—ALB—multiple sclerosis	1.91e-05	0.000566	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SRM—multiple sclerosis	1.91e-05	0.000564	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.9e-05	0.000564	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.9e-05	0.000564	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—RPL5—multiple sclerosis	1.88e-05	0.000556	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—ITGA4—multiple sclerosis	1.88e-05	0.000555	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.87e-05	0.000554	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.87e-05	0.000554	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—IFNB1—multiple sclerosis	1.86e-05	0.000551	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.86e-05	0.000551	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.86e-05	0.000551	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.85e-05	0.000547	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	1.82e-05	0.00054	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	1.82e-05	0.000539	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	1.8e-05	0.000532	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—SLC11A1—multiple sclerosis	1.8e-05	0.000532	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—RRM1—multiple sclerosis	1.78e-05	0.000528	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GPC5—multiple sclerosis	1.78e-05	0.000528	CbGpPWpGaD
Fluorouracil—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.77e-05	0.000524	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.75e-05	0.000517	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—IL1B—multiple sclerosis	1.74e-05	0.000515	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—IL2—multiple sclerosis	1.73e-05	0.000513	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SRM—multiple sclerosis	1.73e-05	0.000513	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—APOE—multiple sclerosis	1.69e-05	0.000501	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—APOE—multiple sclerosis	1.69e-05	0.000501	CbGpPWpGaD
Fluorouracil—ABCC3—NRF2 pathway—TGFB1—multiple sclerosis	1.68e-05	0.000499	CbGpPWpGaD
Fluorouracil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.68e-05	0.000497	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PLEK—multiple sclerosis	1.67e-05	0.000493	CbGpPWpGaD
Fluorouracil—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	1.66e-05	0.000492	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CD28—multiple sclerosis	1.65e-05	0.000488	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.65e-05	0.000487	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.64e-05	0.000486	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.63e-05	0.000484	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	1.63e-05	0.000481	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	1.62e-05	0.000479	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.61e-05	0.000477	CbGpPWpGaD
Fluorouracil—CYP2A6—Biological oxidations—POMC—multiple sclerosis	1.61e-05	0.000475	CbGpPWpGaD
Fluorouracil—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	1.58e-05	0.000469	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	1.55e-05	0.00046	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	1.55e-05	0.000459	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.53e-05	0.000454	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.52e-05	0.000451	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.52e-05	0.000451	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—RRM1—multiple sclerosis	1.48e-05	0.000437	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.46e-05	0.000432	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—POMC—multiple sclerosis	1.45e-05	0.00043	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—POMC—multiple sclerosis	1.45e-05	0.00043	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.44e-05	0.000427	CbGpPWpGaD
Fluorouracil—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.44e-05	0.000425	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CD28—multiple sclerosis	1.44e-05	0.000425	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.38e-05	0.000409	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP27B1—multiple sclerosis	1.34e-05	0.000398	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP24A1—multiple sclerosis	1.34e-05	0.000398	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—ALB—multiple sclerosis	1.32e-05	0.000392	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—ALB—multiple sclerosis	1.32e-05	0.000392	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—BCHE—multiple sclerosis	1.32e-05	0.000391	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.3e-05	0.000385	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.3e-05	0.000385	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—IL2RA—multiple sclerosis	1.28e-05	0.000379	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	1.27e-05	0.000375	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TNF—multiple sclerosis	1.26e-05	0.000374	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	1.26e-05	0.000374	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	1.25e-05	0.000371	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	1.24e-05	0.000367	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GPC5—multiple sclerosis	1.23e-05	0.000364	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	1.22e-05	0.000361	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	1.22e-05	0.000361	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—APOE—multiple sclerosis	1.2e-05	0.000357	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—IL6—multiple sclerosis	1.19e-05	0.000352	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SRM—multiple sclerosis	1.18e-05	0.00035	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	1.18e-05	0.000349	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	1.18e-05	0.000349	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SRM—multiple sclerosis	1.18e-05	0.000348	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CD86—multiple sclerosis	1.18e-05	0.000348	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SELE—multiple sclerosis	1.17e-05	0.000348	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—TGFB1—multiple sclerosis	1.16e-05	0.000343	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.16e-05	0.000343	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—BCHE—multiple sclerosis	1.15e-05	0.000341	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.15e-05	0.000339	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.14e-05	0.000338	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.14e-05	0.000337	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	1.13e-05	0.000333	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GPC5—multiple sclerosis	1.12e-05	0.00033	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.12e-05	0.00033	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	1.11e-05	0.000327	CbGpPWpGaD
Fluorouracil—CYP2C8—Biological oxidations—POMC—multiple sclerosis	1.1e-05	0.000325	CbGpPWpGaD
Fluorouracil—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	1.06e-05	0.000312	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CCR5—multiple sclerosis	1.04e-05	0.000309	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—POMC—multiple sclerosis	1.04e-05	0.000306	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—BCHE—multiple sclerosis	1.02e-05	0.000303	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CD86—multiple sclerosis	1.02e-05	0.000303	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—IL6—multiple sclerosis	1.02e-05	0.000302	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—RRM1—multiple sclerosis	1.02e-05	0.000301	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HLA-A—multiple sclerosis	1.02e-05	0.000301	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.01e-05	0.000298	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	1e-05	0.000297	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.95e-06	0.000295	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.84e-06	0.000291	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SRM—multiple sclerosis	9.63e-06	0.000285	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—APOE—multiple sclerosis	9.49e-06	0.000281	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—ALB—multiple sclerosis	9.44e-06	0.000279	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—ALB—multiple sclerosis	9.27e-06	0.000274	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—RRM1—multiple sclerosis	9.25e-06	0.000274	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CCR5—multiple sclerosis	9.08e-06	0.000269	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.97e-06	0.000266	CbGpPWpGaD
Fluorouracil—CYP2C9—Biological oxidations—POMC—multiple sclerosis	8.93e-06	0.000264	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HLA-A—multiple sclerosis	8.85e-06	0.000262	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CD80—multiple sclerosis	8.58e-06	0.000254	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.53e-06	0.000253	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—ITGA4—multiple sclerosis	8.49e-06	0.000251	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—BCHE—multiple sclerosis	8.48e-06	0.000251	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IFNB1—multiple sclerosis	8.43e-06	0.000249	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	8.34e-06	0.000247	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	8.34e-06	0.000247	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP24A1—multiple sclerosis	8.29e-06	0.000245	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP27B1—multiple sclerosis	8.29e-06	0.000245	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—APOE—multiple sclerosis	8.26e-06	0.000245	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SRM—multiple sclerosis	8.23e-06	0.000244	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.15e-06	0.000241	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.1e-06	0.00024	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	8.1e-06	0.00024	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.02e-06	0.000237	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—MYC—multiple sclerosis	7.97e-06	0.000236	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—APOE—multiple sclerosis	7.95e-06	0.000235	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	7.8e-06	0.000231	CbGpPWpGaD
Fluorouracil—CYP1A2—Biological oxidations—POMC—multiple sclerosis	7.63e-06	0.000226	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GPC5—multiple sclerosis	7.62e-06	0.000226	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GPC5—multiple sclerosis	7.58e-06	0.000224	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—IL2—multiple sclerosis	7.51e-06	0.000222	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CD80—multiple sclerosis	7.47e-06	0.000221	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TYK2—multiple sclerosis	7.24e-06	0.000214	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MYC—multiple sclerosis	7.12e-06	0.000211	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MAPK1—multiple sclerosis	6.97e-06	0.000206	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—APOE—multiple sclerosis	6.92e-06	0.000205	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—POMC—multiple sclerosis	6.83e-06	0.000202	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	6.79e-06	0.000201	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	6.79e-06	0.000201	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.63e-06	0.000196	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	6.6e-06	0.000195	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CD4—multiple sclerosis	6.55e-06	0.000194	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—RRM1—multiple sclerosis	6.32e-06	0.000187	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TYK2—multiple sclerosis	6.31e-06	0.000187	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—RRM1—multiple sclerosis	6.28e-06	0.000186	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—ALB—multiple sclerosis	6.23e-06	0.000184	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GPC5—multiple sclerosis	6.21e-06	0.000184	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—APOE—multiple sclerosis	6.16e-06	0.000182	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—POMC—multiple sclerosis	5.95e-06	0.000176	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.88e-06	0.000174	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TGFB1—multiple sclerosis	5.86e-06	0.000173	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—BCHE—multiple sclerosis	5.85e-06	0.000173	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IL2RA—multiple sclerosis	5.8e-06	0.000172	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	5.8e-06	0.000172	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	5.8e-06	0.000172	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—MAPK1—multiple sclerosis	5.75e-06	0.00017	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CD4—multiple sclerosis	5.7e-06	0.000169	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.67e-06	0.000168	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ALB—multiple sclerosis	5.42e-06	0.00016	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—BCHE—multiple sclerosis	5.31e-06	0.000157	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GPC5—multiple sclerosis	5.3e-06	0.000157	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—POMC—multiple sclerosis	5.3e-06	0.000157	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	5.15e-06	0.000152	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—RRM1—multiple sclerosis	5.14e-06	0.000152	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—APOE—multiple sclerosis	5.1e-06	0.000151	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—STAT3—multiple sclerosis	5.07e-06	0.00015	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	5.05e-06	0.000149	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.9e-06	0.000145	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.87e-06	0.000144	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ALB—multiple sclerosis	4.83e-06	0.000143	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MYC—multiple sclerosis	4.71e-06	0.00014	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TGFB1—multiple sclerosis	4.7e-06	0.000139	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MAPK1—multiple sclerosis	4.61e-06	0.000137	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—STAT3—multiple sclerosis	4.42e-06	0.000131	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—RRM1—multiple sclerosis	4.39e-06	0.00013	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—POMC—multiple sclerosis	4.38e-06	0.00013	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.21e-06	0.000125	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.19e-06	0.000124	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—multiple sclerosis	4.1e-06	0.000121	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TGFB1—multiple sclerosis	4.09e-06	0.000121	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MAPK1—multiple sclerosis	4.01e-06	0.000119	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ALB—multiple sclerosis	4e-06	0.000118	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.99e-06	0.000118	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.84e-06	0.000114	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—BCHE—multiple sclerosis	3.63e-06	0.000107	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—BCHE—multiple sclerosis	3.61e-06	0.000107	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6—multiple sclerosis	3.54e-06	0.000105	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—APOE—multiple sclerosis	3.52e-06	0.000104	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.43e-06	0.000101	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.41e-06	0.000101	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IL2—multiple sclerosis	3.4e-06	0.000101	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—APOE—multiple sclerosis	3.2e-06	9.46e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.12e-06	9.25e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6—multiple sclerosis	3.08e-06	9.13e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—POMC—multiple sclerosis	3.02e-06	8.95e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.95e-06	8.74e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.93e-06	8.67e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ALB—multiple sclerosis	2.76e-06	8.16e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—POMC—multiple sclerosis	2.75e-06	8.13e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.67e-06	7.9e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB1—multiple sclerosis	2.65e-06	7.85e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—MAPK1—multiple sclerosis	2.6e-06	7.7e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.52e-06	7.47e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ALB—multiple sclerosis	2.5e-06	7.41e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—APOE—multiple sclerosis	2.18e-06	6.46e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—APOE—multiple sclerosis	2.17e-06	6.43e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—POMC—multiple sclerosis	1.88e-06	5.55e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—POMC—multiple sclerosis	1.86e-06	5.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APOE—multiple sclerosis	1.78e-06	5.26e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALB—multiple sclerosis	1.71e-06	5.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—POMC—multiple sclerosis	1.53e-06	4.52e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOE—multiple sclerosis	1.52e-06	4.49e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALB—multiple sclerosis	1.39e-06	4.12e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—POMC—multiple sclerosis	1.3e-06	3.86e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALB—multiple sclerosis	1.19e-06	3.52e-05	CbGpPWpGaD
